Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment

By Schifitto Giovanni   Zhong Jianhui   Gill David   Peterson Derick   Gaugh Michelle   Zhu Tong   Tivarus Madalina   Cruttenden Kim   Maggirwar Sanjay   Gendelman Howard   Dewhurst Stephen   Gelbard Harris  

Journal of NeuroVirology, Vol. 15, Iss. 2, 2009-04 ,pp. : 176-186

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy

By Everall I   Vaida F   Khanlou N   Lazzaretto D   Achim C   Letendre S   Moore D   Ellis R   Cherner M   Gelman B   Morgello S   Singer E   Grant I   Masliah E  

Journal of NeuroVirology, Vol. 15, Iss. 5-6, 2009-12 ,pp. : 360-370

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy–treated subjects with human immunodeficiency virus type 1 infection

By Sun Bing   Abadjian Linda   Rempel Hans   Calosing Cyrus   Rothlind Johannes   Pulliam Lynn  

Journal of NeuroVirology, Vol. 16, Iss. 2, 2010-04 ,pp. : 115-124

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The effect of highly active antiretroviral therapy on outcome of central nervous system herpesviruses infection in Cuban human immunodeficiency virus-infected individuals

By Martínez Pedro Ariel   Díaz René   González Daniel   Oropesa Lisset   González Ruby   Pérez Lissette   Viera Jenniffer   Kourí Vivian  

Journal of NeuroVirology, Vol. 13, Iss. 5, 2007-09 ,pp. : 446-451

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients

By Ances Beau   Roc Anne   Korczykowski Marc   Wolf Ronald   Kolson Dennis  

Journal of NeuroVirology, Vol. 14, Iss. 5, 2008-09 ,pp. : 418-424

Ashgate Publishing Ltd

Access to resources Recommend Favorite